[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343608-105":59,"doc-detail-343608-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","dual-view-jointly-learning-improves-personalized-drug-synergy-prediction-abstract","Dual-view jointly learning improves personalized drug synergy prediction - Abstract","","Accurate, robust estimation of synergistic drug combinations is critical for precision medicine, yet many computational predictors remain unreliable, especially when transferring across datasets, because drug-combination mechanisms are complex and cancer samples are heterogeneous. JointSyn is introduced, using dual-view jointly learning to predict sample-specific effects from drug features and cell features. It achieves stronger accuracy and robustness across benchmarks and supports fine-tuning for generalizing to novel combinations or new cancer samples from limited measurements. An estimated pan-cancer drug-synergy atlas and cancer-specific differential patterns further validate its potential.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/dual-view-jointly-learning-improves-personalized-drug-synergy-prediction-abstract/343608/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/dual-view-jointly-learning-improves-personalized-drug-synergy-prediction-abstract/343608.png","ImageObject",300,407,{"name":92,"@type":93},"Sage","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What problem does JointSyn address in drug synergy prediction?","Question",{"text":113,"@type":114},"JointSyn targets the challenge that existing computational methods often produce unreliable synergy predictions, particularly for cross-dataset settings caused by complex combination mechanisms and heterogeneous cancer samples.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does JointSyn model drug synergy?",{"text":118,"@type":114},"JointSyn uses dual-view jointly learning to predict sample-specific effects of a drug combination from both drug features and cell (cancer) features, where each view captures synergy-related characteristics and complements the final prediction.",{"name":120,"@type":111,"acceptedAnswer":121},"How is JointSyn improved for predicting new combinations or cancer samples?",{"text":122,"@type":114},"JointSyn can be fine-tuned to improve generalization, enabling prediction of novel drug combinations or cancer samples using only a small number of experimental measurements.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},343608,1790309563,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Data and text mining  \nDual-view jointly learning improves personalized drug synergy prediction  \nXueliang Li 1, Bihan Shen 1, Fangyoumin Feng 1, Kunshi Li1, Zhixuan Tang1, Liangxiao Ma 2, Hong Li 1, 􀀃  \n1CAS Key Laboratory of Computational Biology, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China  \n2 Bio-Med Big Data Center, CAS Key Laboratory of Computational Biology, Shanghai Institute of Nutrition and Health, Chinese Academy of Science, Shanghai 200031, China  \n􀀃 Corresponding author: CAS Key Laboratory of Computational Biology, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Yueyang  \nRoad 320, Shanghai. E-mail: [lihong01@sinh.ac.cn](lihong01@sinh.ac.cn)  \nAssociate Editor: Zhiyong Lu  \nAbstract  \nMotivation: Accurate and robust estimation of the synergistic drug combination is important for medicine precision. Although some computational methods have been developed, some predictions are still unreliable especially for the cross-dataset predictions, due to the complex mechanism of drug combinations and heterogeneity of cancer samples.  \nResults: We have proposed JointSyn that utilizes dual-view jointly learning to predict sample-specific effects of drug combination from drug and cell features. JointSyn outperforms existing state-of-the-art methods in predictive accuracy and robustness across various benchmarks. Each view of JointSyn captures drug synergy-related characteristics and makes complementary contributes to the final prediction of the drug combination. Moreover, JointSyn with fine-tuning improves its generalization ability to predict a novel drug combination or cancer sample using a small number of experimental measurements. We also used JointSyn to generate an estimated atlas of drug synergy for pan-cancer and explored the differential pattern among cancers. These results demonstrate the potential of JointSyn to predict drug synergy, supporting the development of personalized combinatorial therapies.  \nAvailability and implementation: Source code and data are available at [https://github.com/LiHongCSBLab/JointSyn](https://github.com/LiHongCSBLab/JointSyn).  \n1 Introduction  \nTraditional and modern medicines have always utilized the combinatorial drug therapies to better treat cancers (Foucquierand Guedj 2015). Compared with monotherapies, the drug combinations may improve treatment efficacy (Fisusi and Akala 2019, Sicklick et al. 2019), reduce toxicity and side effects (AlLazikani et al. 2012, Iqubal et al. 2022) and decrease the drug resistance (Tyers and Wright 2019, Liu et al. 2020). However, responses to the same drug combination may vary largely among patients due to the high heterogeneity of cancers (Sicklick et al. 2019). How to select suitable drug combination for an individual is a key challenge in personalized cancer therapy (Fan et al. 2021). With the development of high-throughput drug combination screening in recent years (He et al. 2018), the responses of drug combinations can be tested on multiple cancer cell lines simultaneously (Astashkina et al. 2012). However, exhaustive searching of the entire combination space is impossible due to high costs and time consumption for the exponential increase of potential combinations (Macarron et al. 2011, Goswami et al. 2015). Therefore, computational methods are needed to discover candidate synergistic drug combinations for experimental validation.  \nO’Neil et al. (2016) published a large-scale study, including 22 737 experimental measurements of 38 drugs on 39 cancer  \ncell lines. NCI published a larger study of the drug combination, including 304 549 measurements of 104 drugs on 60 cancer cell lines (Holbeck et al. 2017). Based on observed responses, a synergy score is calculated for each “drug1-drug2-cell line” triple and the triple can be classified as synergistic, antagonistic, or additive. DrugComb collected multiple experimental datasets","cbCaibuGghnr4lVa","https://ap.wps.com/l/cbCaibuGghnr4lVa","pdf",8141457,"English","# Abstract\n## Motivation\n## Results\n## Availability and implementation\n# 1 Introduction","[{\"question\":\"What problem does JointSyn address in drug synergy prediction?\",\"answer\":\"JointSyn targets the challenge that existing computational methods often produce unreliable synergy predictions, particularly for cross-dataset settings caused by complex combination mechanisms and heterogeneous cancer samples.\"},{\"question\":\"How does JointSyn model drug synergy?\",\"answer\":\"JointSyn uses dual-view jointly learning to predict sample-specific effects of a drug combination from both drug features and cell (cancer) features, where each view captures synergy-related characteristics and complements the final prediction.\"},{\"question\":\"How is JointSyn improved for predicting new combinations or cancer samples?\",\"answer\":\"JointSyn can be fine-tuned to improve generalization, enabling prediction of novel drug combinations or cancer samples using only a small number of experimental measurements.\"}]","Dual-view jointly learning improves personalized drug synergy prediction - Abstract | PDF",1790051567,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3206be6f14876c11727ca82dae2fd38b.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e5b731e895850661c729273f42c4f727.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9694a9d9c49adaac3bd5df5ee4e4a9a9.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c89db2a9b82f09cc02285f7288111073.webp",980,1268]